biotech news today obesity drugs glp-1 The race may have a new contender. ๐ Regeneron reported Phase 3 data showing its drug candidate delivered up to 19.3% weight loss at 48 weeks, approaching the efficacy seen ADA '26: Lilly's dominance, Pfizer's
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Sep 5 - Sep 10












:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)















